Prof. Dr. med. Rainer Haas is a leading oncohematologist in Germany, currently serving as Chief Physician at University Hospital Düsseldorf. Born in Stuttgart and raised in Karlsruhe, he pursued his medical studies at the prestigious Ruprecht-Karls University in Heidelberg, where he later specialized in oncohematology. His academic brilliance was evident early on, earning a scholarship from the Mildred-Scheel Foundation and conducting advanced stem cell research at the Ontario Cancer Institute in Toronto. Over a remarkable career spanning more than 38 years, Prof. Haas has played a pivotal role in the development of bone marrow transplantation and gene therapy. His professional journey includes senior roles at leading institutions such as the University of Mainz, Fred Hutchinson Cancer Research Center (USA), and the German Cancer Research Center (DKFZ). Today, as a top-rated hematologist and oncologist in Düsseldorf, Dr. Haas is not only known for his clinical expertise but also for his dedication to medical research and training. His reputation makes him one of the most respected and famous hematologists in Germany, trusted by both peers and international patients for treating complex blood cancers.
Prof. Dr. med. Rainer Haas is widely regarded as a top expert in oncohematology in Germany. His clinical interests include bone marrow transplantation, gene therapy, and the treatment of blood cancers such as leukemia and lymphoma. Over the years, he has spearheaded research into stem cell transplantation, particularly its role in hematologic malignancies. After completing his specialization in oncohematology in 1984 at the University of Heidelberg, Prof. Haas pursued advanced fellowships in Canada and later served as a visiting consultant in the USA at Fred Hutchinson Cancer Research Center. His vast experience includes senior appointments at the University of Mainz and the University Hospital Düsseldorf, where he currently leads the oncohematology department. Prof. Haas has published over 150 peer-reviewed papers and remains a dedicated member of prestigious medical societies, including the German Society of Hematology and Oncology and the European Hematology Association. His work has significantly influenced clinical protocols for blood disease management, positioning him as a leading doctor in Germany for leukemia and lymphoma treatments.